Goldenwell Biotech (GWLL) Total Current Liabilities (2021 - 2025)
Goldenwell Biotech (GWLL) has disclosed Total Current Liabilities for 4 consecutive years, with $39360.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Total Current Liabilities changed N/A year-over-year to $39360.0, compared with a TTM value of $39360.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $1860.0, changed N/A over the prior year.
- Total Current Liabilities was $39360.0 for Q3 2025 at Goldenwell Biotech, down from $64360.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $159266.0 in Q4 2021 and bottomed at $1860.0 in Q4 2024.
- Average Total Current Liabilities over 4 years is $61648.8, with a median of $39856.0 recorded in 2022.
- Peak annual rise in Total Current Liabilities hit 76.88% in 2022, while the deepest fall reached 76.88% in 2022.
- Year by year, Total Current Liabilities stood at $159266.0 in 2021, then tumbled by 81.71% to $29126.0 in 2022, then tumbled by 93.61% to $1860.0 in 2024, then surged by 2016.13% to $39360.0 in 2025.
- Business Quant data shows Total Current Liabilities for GWLL at $39360.0 in Q3 2025, $64360.0 in Q2 2025, and $1860.0 in Q4 2024.